Pharmaceuticals, Biotechnology and Life Sciences
TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/FSDDF?src=hash" target="_blank"gt;#FSDDFlt;/agt;–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), today announced the appointment…
– KVD900 Phase 1 Data Show Rapid Suppression of Plasma Kallikrein Activity and is Well Tolerated for Potential Use as…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement…
Partnership accelerates access to inebilizumab in China and supports the mission of both companies to bring transformative therapies to more…
Enrollment of cohort 2 was completed six months ahead of schedule Cohort 2 had a target enrollment of 87 NSCLC…
DUBLIN–(BUSINESS WIRE)–The “Nasopharyngeal Cancer – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Nasopharyngeal Cancer –…
DUBLIN–(BUSINESS WIRE)–The “Osteosarcoma – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Osteosarcoma – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “Osteoarthritis – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Osteoarthritis – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “Diabetic Macular Edema – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Diabetic Macular…